Rationale: Bone morphogenic protein (BMP)4 can stimulate superoxide production and exert proinflammatory effects on the endothelium. The underlying mechanisms of how BMP4 mediates endothelial dysfunction and hypertension remain elusive. Objective: To elucidate the cellular pathways by which BMP4-induced endothelial dysfunction is mediated through oxidative stress-dependent upregulation of cyclooxygenase (COX)Conclusions: We show for the first time that ROS serve as a pathological link between BMP4 stimulation and the downstream COX-2 upregulation in endothelial cells, leading to endothelial dysfunction through ROS-dependent p38 MAPK activation. This BMP4/ROS/COX-2 cascade is important in the maintenance of endothelial dysfunction in hypertension. (Circ Res. 2010;107:984-991.)
BMP4 induces hypertension in mice partly through stimulating the expression and activity of vascular NADPH oxidases and the subsequent overproduction of ROS, which disturbs endothelial function. 11 However, the exact underlying mechanisms of BMP4induced oxidative stress and endothelial dysfunction remain elusive. COX-2 could be involved because ROS triggers the release of prostanoids via the action of COX-2. 12 COX-2 is upregulated in atherosclerotic lesions 13 and catalyzes the production of the majority of vascular prostanoids in human atherosclerotic areas. 14 COX-2 inhibition improves endothelial function in patients with hypertension and coronary heart disease. 15, 16 COX-2 can be also expressed constitutively in rat and human vascular endothelial cells, 17, 18 and its expression is upregulated with aging in hamster aortae, 19 suggesting that COX-2 plays an important role in both the physiological and pathological regulation of vascular function, depending on the level of its expression and activity.
The present study hypothesizes that upregulated COX-2 in endothelial cells plays a critical role in BMP4-induced endothelial dysfunction. Mouse, rat, and human arteries were used to investigate whether or not BMP4 impairs EDRs and facilitates endothelium-dependent contractions (EDCs) and whether oxidative stress serves as a link between BMP4 stimulation and downstream COX-2 upregulation. Finally, the possible clinical relevance of this BMP4/COX-2 pathway in hypertension was examined.
Methods
An expanded Methods section is available in the Online Data Supplement at http://circres.ahajournals.org.
Animals
C57BL/6J mice, spontaneously hypertensive rats (SHR), and Wistar-Kyoto (WKY) rats were supplied by Chinese University of Hong Kong Laboratory Animal Center, whereas COX-1 Ϫ/Ϫ or COX-2 Ϫ/Ϫ mice were supplied by University of Hong Kong. All of the experiments were conducted under our institutional guidelines for the humane treatment of laboratory animals.
Human Renal Arteries Specimens
The present study was approved by the Joint Chinese University of Hong Kong-New Territories East Cluster Clinical Research Ethics Committee. Human renal arteries were harvested from nephrectomy specimens from normotensive and hypertensive patients after obtaining informed consent. The mean age of patients was 62.5 years (range, 44 to 70 years). The indications for surgery included tumor (5 patients) and poorly functioning kidney (1 patient) in each group. History of hypertension was defined as having persistent elevated blood pressure, systolic pressure of Ͼ140 mm Hg, or diastolic pressure of Ͼ90 mm Hg and requiring medical therapy.
Blood Vessel Preparation
Adult male mice and rats were euthanized by CO 2 suffocation, and mouse aortae or rat intralobar renal arteries were removed and placed in ice-cold Krebs solution (mmol/L): 119 NaCl, 4.7 KCl, 2.5 CaCl 2 , 1 MgCl 2 , 25 NaHCO 3 , 1.2 KH 2 PO 4 , and 11 D-glucose. Arteries were cleaned of adhering adipose tissue and cut into ring segments of 2 mm in length. As described previously, 20,21 mouse aortic rings were incubated for 12 hours in DMEM (Gibco, Grand Island, NY) culture media with 10% FBS (Gibco), 100 IU of penicillin, and 100 g/mL streptomycin and were placed in a CO 2 incubator with 95% O 2 plus 5% CO 2 with and without BMP4. After 12 hours of incubation, rings were suspended in a myograph (Danish Myo Technology, Aarhus, Denmark) for recording of changes in isometric tension. Briefly, 2 steel wires (40 m in diameter) were inserted through the lumen of the vessel, and each wire was fixed to the jaws built in the myograph. The organ chamber was filled with 5 mL of Krebs solution and gassed by 95% O 2 /5% CO 2 at 37°C (pHϷ7.4). Each ring was stretched to 3 mN, an optimal tension, and then allowed to stabilize for 90 minutes before the start of each experiment.
Functional Studies
Some arterial rings were exposed to BMP4 in control solution or in the presence of one of the following inhibitors: noggin (BMP4 antagonist, 100 ng/mL), apocynin (NADPH oxidase inhibitor, 100 mol/L), tempol (SOD mimetic, 100 mol/L), or SB202190 (p38 mitogen-activated protein kinase [MAPK] inhibitor; 10 mol/ L). After incubation with BMP4 for 12 hours, rings were suspended in a myograph and subjected to 30-minute exposure to S18886 (thromboxane prostanoid receptor antagonist; 100 nmol/L), celecoxib (3 mol/L), or sc-560 (COX-1 inhibitor, 0.3 mol/L). The concentration of these individual inhibitors is known to be specific against the respective target. 19, 22 The first series of experiments examined the alterations in EDRs. Rings were contracted with phenylephrine (1 mol/L) to establish a stable tension and acetylcholine (ACh) was then added cumulatively (1 nmol/L to 10 mol/ L). ACh-induced relaxations were abolished by 100 mol/L N Gnitro-L-arginine methyl ester (L-NAME) (NOS inhibitor), or by endothelium removal. The second set of experiments examined EDCs. Aortic rings were first treated for 30 minutes with 100 mol/L L-NAME to eliminate the interference of endotheliumderived nitric oxide (NO), a procedure commonly adopted to unmask ACh-induced EDCs, 19, 23 and then contractions were elicited by ACh (0.1 to 30 mol/L). EDC was expressed as active tension by dividing the peak contraction (mN) by 2ϫ vessel length in millimeters. Intralobar renal arteries were dissected from SHR and WKY rats and subjected to 12-hour organ culture in DMEM in control and in the presence of 100 ng/mL noggin or 3 mol/L celecoxib. Both EDRs and EDCs were studied and compared in different treatment groups. Human arteries were treated using the same protocol as for rat renal arteries.
ROS Detection by Electron Paramagnetic Resonance Spin Trapping
To measure ROS released from arterial tissues, electron paramagnetic resonance (EPR) was performed with 1-hydroxy-2,2,6,6tetramethyl-4-oxo-piperidine hydrochloride (TEMPONE-H, Alexis) and 5,5-dimethyl-1-pyrroline-N-oxide (DMPO, Alexis) as spin trap agents. All EPR samples were placed in 100-L glass tubes and 
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Constructs, Lentivirus Production, and Transduction
We have designed 2 short hairpin (sh)RNAs targeting mouse BMP receptor 1a: shRNA1 (5Ј-GCT GTT AAA TTC AAC AGT GAC ACA AAT G-3Ј) and shRNA2 (5Ј-TCT CTC TAT GAC TTC CTG AAA TGT GCC A-3Ј); and 1 shRNA targeting firefly luciferase as a control: 5Ј-TGC GCT GCT GGT GCC AAC CCT ATT CT-3Ј. DNA fragments containing shRNAs sequence were synthesized and cloned into lentiviral RNA interference vector pLUNIG after annealing as described previously. 24, 25 The VSV-G-pseudotyped lentiviruses were produced by cotransfecting 293T cells with the transfer vector and 3 packaging vectors (pMDLg/pRRE, pRSV-REV, and pCMV-VSVG) as described previously. Subsequent purification was performed using ultracentrifugation. Mouse blood vessels were cultured in 24-well plates and were transduced with lentivirus and 8 g/mL polybrene (Sigma).
Statistical Analysis
Results represent meansϮSEM from different animals or humans. Concentration-response curves were analyzed by nonlinear regression curve fitting using GraphPad Prism software (Version 4.0, San Diego, Calif). The protein expression was quantified by densitometer (FluorChem, Alpha Innotech, San Leandro, Calif) and normalized to GAPDH and then compared with control. Statistical significance was determined by 2-tailed Student's t test or 1-way ANOVA followed by the Bonferroni post hoc test when more than 2 treatments were compared. PϽ0.05 indicates statistically significant difference.
Results
BMP4 Impairs EDRs
ACh-induced EDRs in mouse aortae were impaired in a concentration-dependent manner by 12 hours of exposure to BMP4 at 10, 20, and 80 ng/mL (Figure 1 A) . BMP4 exposure also reduced EDRs in a time-dependent manner at 12, 18, and 24 hours ( Figure 1B) . The BMP4-treated aortae contracted in response to concentrations of ACh of Ͼ1 mol/L, as shown in the representative traces ( Figure 1C ). BMP4 antagonist noggin at 100 ng/mL prevented BMP4-induced reduction of EDRs ( Figure 1D ). By contrast, endothelium-independent relaxations to sodium nitroprusside were unaffected by BMP4 ( Figure 1E ).
BMP4-Induced Endothelial Dysfunction Is Mediated Through COX-2
Thirty-minute treatment with COX-2 inhibitor celecoxib (3 mol/L) or thromboxane prostanoid receptor antagonist S18886 (0.1 mol/L) prevented the impaired EDRs in BMP4-treated aortae, whereas COX-1 inhibitor sc-560 (0.3 mol/L) had no effect (Figure 2A ). BMP4 failed to impair EDRs of aortae from COX-2 Ϫ/Ϫ mice as compared with those from wild-type or COX-1 Ϫ/Ϫ mice ( Figure 2B and 2C). Celecoxib or S18886 also abolished BMP4-induced ACh-mediated EDCs in the presence of nitric oxide synthase inhibitor L-NAME (100 mol/L), whereas sc-560 had less effect ( Figure 2D) . Similarly, the ability of BMP4 to enhance EDC response was also abolished in aortae from COX-2 Ϫ/Ϫ mice, as compared with those from wild-type or COX-1 Ϫ/Ϫ mice ( Figure 2E and 2F).
BMP4-Induced COX-2 Upregulation Is Mediated Through BMP Receptor 1A
BMP4 antagonist noggin prevented EDCs ( Figure 3A ) and COX-2 upregulation ( Figure 3B ) in BMP4-treated aortae. Knocking down BMP receptor (BMPR)1A by shRNA also abolished EDCs ( Figure 3C ). Knockdown of BMPR1A reduced BMPR1a expression and COX-2 upregulation in BMP4-treated mouse aortae ( Figure 3D ). BMP4-induced COX-2 upregulation in mouse aortae was mainly confined to endothelial cells as the removal of endothelium significantly reduced the COX-2 expression showed by Western blotting ( Figure 3E ). Immunostaining also showed a similar increase of COX-2 expression in the endothelium triggered by BMP4 in mouse aortae (Online Figure I ).
BMP4 Upregulates COX-2 Through ROS and MAPK
Cotreatment of NADPH oxidases inhibitor apocynin (100 mol/L) or ROS scavenger tempol (100 mol/L) significantly improved EDRs in BMP4-treated aortae ( Figure  4A ). Cotreatment with specific p38 MAPK inhibitor SB202190 at 10 mol/L also improved the reduced EDRs ( Figure 4B ). Likewise, apocynin, tempol, or SB202190 prevented EDCs in BMP4-treated aortae ( Figure 4C and 4D) . Western blotting demonstrated that COX-2 upregulation by BMP4 was reduced by apocynin, tempol, or SB202190, but not by extracellular signal-regulated kinase inhibitor PD98059 (10 mol/L) or c-Jun N-terminal kinase inhibitor SP600125 (10 mol/L) ( Figure 4E and 4F) . In primary culture of murine aortic endothelial cells, BMP4-induced COX-2 upregulation and p38 MAPK phosphorylation was abolished by noggin, tempol, apocynin, or SB202190, whereas the COX-1 expression remained unaffected ( Figure  5A and 5B).
BMP4 Increases ROS Production
BMP4 significantly elevated ROS production in AChstimulated (10 mol/L) aortae, as determined by EPR spectroscopy ( Figure 6A and 6B) . Noggin, apocynin, tempol, or removal of endothelium significantly inhibited the ROS production in BMP4-treated mouse aortae, whereas SB202190, sc-560, or celecoxib had no effect. In aortae from COX-1 Ϫ/Ϫ or COX-2 Ϫ/Ϫ mice, BMP4 induced a similar increase of ROS production as compared with aortae from wild-type mice ( Figure 6C ).
Association Between BMP4 and COX-2 in Hypertensive Rats and Human Subjects
Noggin or celecoxib reversed the impaired EDRs in SHR renal arteries as compared with those from WKY ( Figure 7A and 7B). Noggin or celecoxib abolished the enhanced EDCs in SHR renal arteries as compared with WKY rat arteries ( Figure 7C and 7D ). Noggin also prevented the increased expression of both BMP4 and COX-2 and inhibited the increased phosphorylation of p38 MAPK in SHR renal arteries ( Figure 7E through 7G ). In addition, SB202190 inhibited the increased COX-2 expression and p38 phosphorylation in SHR renal arteries ( Figure 7H and 7I) .
In renal arteries from hypertensive patients, noggin or celecoxib significantly enhanced ACh-induced EDRs ( Figure  8A and 8B) . The expression levels of both BMP4 and COX-2 were higher in arteries from hypertensive patients than in those from normotensive subjects ( Figure 8C ). Noggin treatment reduced BMP4 and COX-2 expression in renal arteries from hypertensive patients ( Figure 8D ). In renal arteries from normotensive patients, BMP4 reduced the ACh-induced EDRs, and caused COX-2 upregulation, which was prevented by noggin ( Figure 8E and 8F ).
Discussion
The present study demonstrates that upregulated expression of COX-2 plays an essential role in BMP4-induced endothe- lial dysfunction. We demonstrate for the first time that the impaired EDRs and exaggerated EDCs in the BMP4-treated mouse aortae can be abolished by a BMP4 antagonist, COX-2 inhibitor, and ROS scavengers and are absent in COX-2 Ϫ/Ϫ mice. We also show that BMP4 upregulates COX-2 expression through a BMP4/BMPR1A/ROS/p38 MAPK signaling pathway. Furthermore, the present study provides novel evidence for a significant contribution of BMP4 and COX-2 to endothelial dysfunction in spontaneously hypertensive rats and its relevance to human hypertension. Collectively, the present findings clearly support that BMP4 is an upstream activator which triggers overexpression of COX-2 in endothelial cells as an important downstream target enzyme responsible for the initiation and maintenance of endothelial dysfunction. A possible pathophysiological significance of BMP4 in hypertension is thus revealed.
Earlier works by others demonstrated the involvement of BMP4 in atherosclerosis and hypertension and in mediating inflammatory responses of endothelial cells induced by shear stress via a ROS-dependent mechanism involving Nox1based NADPH oxidase. 7, 8 In mouse, the infusion of BMP4 caused hypertension and impaired ACh-induced aortic relaxations through stimulation of NADPH oxidase, 11 suggesting that BMP4 could serve as a potential novel predictor of vascular dysfunction. Indeed, the present results show that BMP4 directly impaired EDRs in blood vessels from 3 different species. The data are in line with BMP4-induced endothelial dysfunction in rat carotid arteries. 6 The harmful effect of BMP4 on endothelial cells is confirmed by the use of noggin. Like other members of the transforming growth factor-␤ superfamily, BMPs exert their cellular actions via membrane receptor complex (BMPR1a, -1b, and -2). 26, 27 Existing evidence suggests that BMPR1a plays an important role in the formation of blood vessels and of the atrioventricular valves. 28, 29 The present study used shRNA to knock down BMPR1a in the mouse aortae and shows that the detrimental vascular action of BMP4 is mediated through the BMP receptor.
The present study also demonstrates that BMP4 facilitates EDCs, which is a pathophysiological response seen in hypertension. Similar to the previous demonstration of the pivotal role of COX-2 in the appearance of EDCs in hamster aortae, 19 BMP4-induced EDC is abolished by COX-2 inhibitor and thromboxane prostanoid receptor antagonist, suggesting that COX-2-dependent arachidonic acid metabolites act as endothelium-derived contracting factors in BMP4-treated arteries. By contrast, COX-1 mediated EDCs in the aortae of aged mice and spontaneously hypertensive rats, 22 ,30 suggesting a significant difference in the role of COX isoforms, depending on the pathological initiators and species. If the vascular effect of BMP4 depends on the activation of COX-2, then this enzyme could be the target responding to BMP4-induced oxidative stress. The critical role of COX-2 in BMP4-induced endothelial dysfunction is supported by the observations that treatment with celecoxib prevented the BMP4-induced endothelial dysfunction. More importantly, BMP4 lost its ability to impair endothelial function in COX-2 Ϫ/Ϫ mice. ROS produced by Nox1-based NADPH oxidase is the major downstream target of BMP4 to mediate inflammatory vascular responses. 8, 31 In the present study, BMP4 induces ROS production in cultured endothelial cells and in isolated rat arteries, which is in line with previous reports. 8, 31 Moreover, the use of EPR spectroscopy spin trap to assess the ROS production in mouse aortae in situ permitted the confirmation of the endothelial origin of ROS production induced by BMP4 both in the presence and absence of ACh stimulation. The ROS production was not reduced by a selective COX-2 inhibitor and was present in the aortae of COX-2 Ϫ/Ϫ mice. ROS removal by scavengers annulled BMP4-induced COX-2 overexpression. Taken together, these findings imply that ROS induced by BMP4 is responsible for BMP4-mediated upregulation of COX-2, which is constitutively expressed in mouse endothelial cells. By contrast, a specific COX-1 inhibitor did not influence the vascular effect of BMP4. Finally, BMP4 did not alter the expression of COX-1 in mouse aortae and cultured mouse aortic endothelial cells. Collectively, our study provides evidence showing that COX-2 is most likely to serve as the link between BMP4 and endothelial dysfunction.
The present study indicates that p38 MAPK activation participates in the regulation of COX-2 expression because a MAPK inhibitor attenuated COX-2 upregulation and improved endothelial function in BMP4-treated mouse aortae. ROS enhances the activity of p38 MAPK in vascular tis-sues. 32 BMP4 can activate MAPK (p38 and p44/42) in endothelial cells and myocytes. 31, 33 The present findings thus suggest that MAPK activation is functionally coupled to COX-2 upregulation, COX-2-dependent EDCs, and impaired EDRs in response to BMP4. In addition, ROS scavengers prevented the BMP4-induced COX-2 upregulation and phosphorylation of p38 MAPK in cultured mouse endothelial cells, thus confirming that endothelial cells are the primary site of action for BMP4 and also supporting an essential role of ROS-dependent p38 MAPK activation in the harmful action of BMP4.
To further elucidate the pathophysiological significance of BMP4 and COX-2 in endothelial dysfunction, the present study examined the vascular protective effect of the BMP4 antagonist noggin or the COX-2 inhibitor celecoxib in spontaneously hypertensive rats. Treatment of SHR renal arteries with either noggin or celecoxib normalized relaxations to the level in WKY rat arteries and abolished EDCs. Although the infusion of BMP4 causes hypertension in healthy mice, 11 it was unclear whether or not BMP4 is a biomarker or is actually linked to essential hypertension. The present study shows a marked increase of BMP4 and COX-2 in hypertensive animals, and both were attenuated by noggin, thus suggesting an association between BMP4 and COX-2 in hypertension. In addition, ROS scavengers also improved EDRs and attenuated EDCs in renal arteries from SHRs. ROS scavengers also reduced COX-2 expression and p38 MAPK activation without affecting BMP4 expression in renal arteries from SHRs, further confirming the positive role of ROS in mediating BMP4-induced COX-2 upregulation in hypertension (Online Figure II) . Our data also reveal such association in renal arteries from hypertensive patients. However, the present study cannot rule out partial involvement of BMP2 in endothelial dysfunction in hypertension because BMP2 is upregulated in a rat model of hypertension and BMP4 antagonist can also neutralize BMP2. 33 In conclusion, the present study demonstrates a critical role of endothelial COX-2 in BMP4-induced endothelial dysfunction. BMP4-induced oxidative stress upregulates COX-2 in endothelial cells. In addition, the BMP4 antagonist noggin protects endothelial function in hypertension. Because both BMP4 and COX-2 are expressed in hypertensive human renal arteries, the present data may be relevant to cardiovascular disease. Indeed, the present findings in mouse, rat, and human arteries supports an important role of BMP4-dependent COX-2 in endothelial dysfunction in hypertension. Our results also suggest that the BMP4 signaling cascade could be a potential target for pharmacological intervention to prevent COX-2-dependent vascular dysfunction.
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